breast cancer
Conditions
Interventions
Experimental group:At the end of the operation, 0.1mg/kg haloperidol were given
Control group:At the end of the operation, 0.1mg/kg saline were given
Sponsors
The First Affiliated Hospital of Chongqing Medical University
Eligibility
Sex/Gender
Female
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Breast cancer patients aged 18 - 80 years old, with ASA (American Society of Anesthesiologists Physical Status Classification System) class I - III. 2. Undergoing breast cancer surgery under combined intravenous - inhalation anesthesia. 3. Signing the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients transferred to the ICU after surgery. 2. Radical mastectomy with anesthesia duration longer than 6 hours. 3. Emergency surgery. 4. Patients who abuse drugs or have long - term use of psychotropic drugs. 5. Use of oral sedative and hypnotic drugs during the peri - operative period. 6. Patients with obstructive sleep apnea syndrome. 7. Patients who cannot cooperate to complete the sleep score and have communication barriers. 8. Patients who experience serious adverse events during the peri - operative period (such as massive blood transfusion, infection, etc.). 9. Excessive noise in the ward environment. 10. Patients with severe arrhythmia and serious cardiovascular diseases. 11. Patients with basal ganglia lesions, Parkinson's disease, Parkinsonism, severe central nervous depression, depression, and those allergic to this product.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Richards-Campbell Sleep Questionnaire;Postoperative adverse reactions; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pittsburgh Sleep Quality Index, PSQI;(Self-Rating Anxiety Scale,SAS; Patient Health Questionnaire-9,PHQ-9;Numeric Rating Scale,NRS;Quality of Recovery Questionnaire-15 ,,QoR-15; | — |
Countries
China
Contacts
Public ContactJin Gao
The First Affiliated Hospital of Chongqing Medical University
Outcome results
None listed